The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksR&Q Insurance Regulatory News (RQIH)

Share Price Information for R&Q Insurance (RQIH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.915
Bid: 1.75
Ask: 2.40
Change: -0.05 (-2.35%)
Spread: 0.65 (37.143%)
Open: 1.915
High: 1.915
Low: 1.915
Prev. Close: 2.125
RQIH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

PDMR/Director Shareholding and Total Voting Rights

27 Oct 2023 16:52

RNS Number : 6018R
R&Q Insurance Holdings Ltd
27 October 2023
 

 

R&Q Insurance Holdings Ltd

 

("R&Q" or the "Company")

 

PDMR/Director Shareholding and Total Voting Rights

 

 

27 October 2023

 

R&Q Insurance Holdings Ltd (AIM: RQIH) ("R&Q" or the "Group"), the leading non-life global specialty insurance company focusing on the Program Management ("Accredited") and Legacy Insurance ("R&Q Legacy") businesses, announces that on 23 October 2023, Andrew Pinkes, a PDMR, to fund tax liabilities arising from the vesting of his share award, sold 218,220 Ordinary Shares, which in accordance with his share award agreement, have been purchased by the Company to be held in Treasury.

 

PDMR Dealing

 

Name of Director

Total Restricted Ordinary Shares Vested

Total Ordinary Shares Sold

Total Ordinary Shares Retained

Total R&Q Ordinary Shares now held

% of voting rights

Andrew Pinkes

490,597

218,220

272,377

517,675

0.14%

 

Total Voting Rights

 

As a result of this transaction the total issued share capital will remain 377,395,235 Ordinary Shares. Of which 3,790,917 Ordinary Shares are now held in Treasury. Therefore, the total number of voting rights will be 373,604,318 and may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Enquiries to:

 

R&Q Insurance Holdings Ltd

William Spiegel

Tel: 0207 780 5850

Tom Solomon 

Tel: 0207 780 5850

 

Numis Securities Limited (Nominated Advisor and Joint Broker)

Giles Rolls 

Tel: 020 7260 1000

Charles Farquhar 

 

Barclays Bank PLC (Joint Broker)

Andrew Tusa

 

Tel: 020 7260 1000

 

 

Tel: 020 7632 2322

FTI Consulting

Tom Blackwell

 

Tel: 020 3727 1051

 

 

Notes to Editors:

 

About R&Q 

 

R&Q is a global non-life specialty insurance company. We operate two core, highly complementary, businesses: Program Management and Legacy Insurance. Both these businesses are leaders in their respective markets.

 

Our approach is to deploy our origination and underwriting capabilities, alongside our licensed and rated carriers in the US, EU and the UK, to generate attractive fee returns in Program Management and Legacy Insurance.

 

Legal Entity Identifier (LEI): 2138006K1U38QCGLFC94

 

Website: www.rqih.com

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

 

1

Details of the person discharging managerial responsibility / person closely associated

 

 

a)

 

Name

 

Andrew Pinkes

2

Reason for the notification

 

a)

 

Position/status

 

PDMR (Senior Executive)

 

b)

 

Initial notification/amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

R&Q Insurance Holdings Ltd

 

 

 

b)

 

LEI

 

2138006K1U38QCGLFC94

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Ordinary shares of 2 pence each of the Company

 

 

Identification code

 

Ordinary share ISIN: BMG7371X1065

 

 

b)

 

Nature of transaction

Sale of 218,220 Ordinary Shares

 

c)

 

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

 

1. Par value of 2p at Grant

Par value of 2p: £4,308.9

 

 

 

 

 

2 £0.24

 

 

 

Sale of 218,220 shares for a total consideration of £ 52,372.80

 

 

 

 

d)

 

Aggregated information

 

 

Aggregated volume

As above

 

 

Price

 

As above

 

 

e)

 

Date of transaction

 

23 October 2023

 

 

f)

 

Place of transaction

 

Outside of trading location

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEASEXALNDFFA
Date   Source Headline
24th Apr 20245:40 pmRNSUpdate on proposed sale of Accredited
19th Apr 20247:00 amRNSAppointment of Non-Executive Directors
12th Apr 20247:00 amRNSUpdate on Trading and Sale of Accredited
12th Mar 20242:33 pmRNSTR-1: Notification of major holdings
1st Mar 20247:00 amRNSComment on recent press speculation
11th Jan 20244:01 pmRNSShareholders approve sale of Accredited
4th Jan 20244:27 pmRNSIncrease in the number of Treasury Shares
2nd Jan 20247:00 amRNSRetirement of Alan Quilter
22nd Dec 20237:00 amRNSUpdate on discussions with the BMA
21st Dec 202311:12 amRNSTR-1: Notification of major holdings
14th Dec 20237:00 amRNSPosting of Circular
16th Nov 20239:58 amRNSTR-1: Notification of major holdings
14th Nov 20237:00 amRNSUpdate on Proposed Sale of Accredited
27th Oct 20234:52 pmRNSPDMR/Director Shareholding and Total Voting Rights
26th Oct 20237:00 amRNSLoss Portfolio Transfer
26th Oct 20237:00 amRNSChange of External Auditor
20th Oct 20235:23 pmRNSProposed Sale of R&Q’s Program Management business
16th Oct 202310:59 amRNSTR-1: Notification of major holdings
29th Sep 20237:00 amRNSResults for the half year ended 30 June 2023
22nd Sep 20237:00 amRNSStatement re Press Comment
20th Sep 202311:55 amRNSTR-1: Notification of major holdings
20th Sep 202311:54 amRNSTR-1: Notification of major holdings
16th Aug 20233:36 pmRNSPDMR/Director Shareholding and Total Voting Rights
28th Jul 20233:18 pmRNSResult of Annual General Meeting
18th Jul 20233:22 pmRNSTR-1: Notification of major holdings
17th Jul 20237:00 amRNSAppointment of Non-Executive Director
30th Jun 202310:08 amRNSAppointment of Non-Executive Director
30th Jun 20237:00 amRNSPosting of Annual Report and Notice of AGM
29th Jun 20237:00 amRNSResults for the year ended 31 December 2022
26th Jun 20237:00 amRNSAccredited receives independent AM Best Rating
12th Jun 20237:00 amRNSR&Q raises up to $60 million of new equity
6th Jun 20235:31 pmRNSTR-1: Notification of major holdings
5th Jun 202311:23 amRNSTR-1: Notification of major holdings
2nd Jun 20233:50 pmRNSTR-1: Notification of major holdings
16th May 20239:27 amRNSTR-1: Notification of major holdings
10th May 20232:30 pmRNSTR-1: Notification of major holdings
10th May 202311:26 amRNSTR-1: Notification of major holdings
4th Apr 20237:00 amRNSStrategic & Trading Update
31st Mar 20237:00 amRNSAppointment of Non-Executive Chairman
17th Mar 20237:00 amRNSCompletion of Tradesman Sale
3rd Mar 202312:16 pmRNSTR-1: Notification of major holdings
23rd Feb 20237:00 amRNSProgram Management Update and Sale of Tradesman
17th Jan 20237:00 amRNSProgram Management Update
12th Jan 20237:00 amRNSPDMR/Director Shareholding and Total Voting Rights
6th Jan 20237:00 amRNSJoint venture to acquire legacy liabilities
5th Dec 20227:00 amRNSLoss Portfolio Transfer
31st Oct 20227:00 amRNSQ3 2022 Program Management Update
19th Oct 20224:40 pmRNSSecond Price Monitoring Extn
19th Oct 20224:35 pmRNSPrice Monitoring Extension
18th Oct 20229:24 amRNSTR-1: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.